MyFinsight
Home
About
Contact
phat: the income statement
Download
Download image
Net loss and
comprehensive loss
-$29,973K
(64.98%↑ Y/Y)
Product revenue, net
$49,504K
(202.74%↑ Y/Y)
Total other expense
-$14,702K
(0.53%↑ Y/Y)
Loss from operations
-$15,271K
(78.43%↑ Y/Y)
Interest income
$1,413K
(-61.92%↓ Y/Y)
Gross profit
$43,314K
(209.47%↑ Y/Y)
Cost of revenue
$6,190K
(162.73%↑ Y/Y)
Other expense, net
-$7K
(12.50%↑ Y/Y)
Interest expense
$16,108K
(-12.85%↓ Y/Y)
Total operating
expenses
$58,585K
(-30.91%↓ Y/Y)
Selling, general and
administrative
$51,558K
(-32.25%↓ Y/Y)
Research and development
$7,027K
(-19.16%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Phathom Pharmaceuticals, Inc. (PHAT)
Phathom Pharmaceuticals, Inc. (PHAT)